Gts Securities LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $8.6 Million - $10.1 Million	8,400 Added 43.3%	27,800 $29.2 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $2.65 Million - $3.21 Million	3,000 Added 18.29%	19,400 $20.4 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $3.79 Million - $4.17 Million	-4,200 Reduced 20.39%	16,400 $15.8 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $1.71 Million - $1.94 Million	2,200 Added 11.96%	20,600 $18.1 Million
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $12.7 Million - $15.5 Million	18,400 New	18,400 $15.1 Million

1,535

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.